Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronchiectasis in COPD Patients : Role of Prophylaxis With Inhaled Steroids and Antibiotic
NCT00524095Phase 2Terminated
- Sponsor
- University of Milan
- Start
- Sep 2006
- Primary completion
- Jul 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of azithromycin, fluticasone propionate nasal spray in chronic obstructive pulmonary disease (COPD), bronchiectasis, sponsored by University of Milan. Started Sep 2006; status: terminated.
02
Drugs
azithromycinfluticasone propionate nasal spray
03
Conditions
chronic obstructive pulmonary disease (COPD)bronchiectasis
Beyond the preview
Go deeper on NCT00524095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00524095.